Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

Halozyme Therapeutics, Inc. HALO

Full chart Compare
Set alert

Price alert · HALO

All alert types
102.92 USD -0.71 (-0.69%)

At closeNov 10, 2026, 4:00 AM EST

103.00 +0.08 +0.08%

Pre-market · Nov 10, 4:00 AM ET

101.04 Day range 105.48
61.23 52-week range 134.00
YTD
+52.93%
1 year
+51.33%

Financial health

Altman Z-Score

3.61 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B-2 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 5
  • Debt / Equity 1
  • P/E 2
  • P/B 1

Valuation

P/E 25.5×
FY 2016: -12.2×FY 2017: 44.0×FY 2018: -26.1×FY 2019: -35.5×FY 2020: 45.0×FY 2021: 14.1×FY 2022: 38.4×FY 2023: 17.4×FY 2024: 13.7×FY 2025: 25.5×
FY 2016 5y median 17.4× FY 2025
P/S 5.8×
FY 2016: 8.6×FY 2017: 8.7×FY 2018: 13.8×FY 2019: 13.1×FY 2020: 21.7×FY 2021: 12.8×FY 2022: 11.8×FY 2023: 5.9×FY 2024: 6.0×FY 2025: 5.8×
FY 2016 5y median 6.0× FY 2025
P/B 165×
FY 2016: -38.7×FY 2017: 13.3×FY 2018: 8.4×FY 2019: 27.9×FY 2020: 38.5×FY 2021: 28.7×FY 2022: 45.9×FY 2023: 58.2×FY 2024: 16.7×FY 2025: 165×
FY 2016 5y median 45.9× FY 2025
P/FCF 12.5×
FY 2016: -23.5×FY 2017: 20.8×FY 2018: -38.7×FY 2019: -28.6×FY 2020: 110×FY 2021: 19.0×FY 2022: 33.1×FY 2023: 13.1×FY 2024: 12.9×FY 2025: 12.5×
FY 2016 5y median 13.1× FY 2025
EV/EBITDA 17.6×
FY 2016: -17.7×FY 2017: 33.6×FY 2018: -31.3×FY 2019: -50.2×FY 2020: 39.7×FY 2021: 24.8×FY 2022: 28.7×FY 2023: 13.8×FY 2024: 11.4×FY 2025: 17.6×
FY 2016 5y median 17.6× FY 2025
EV/Sales 7.2×
FY 2016: 9.6×FY 2017: 8.8×FY 2018: 14.3×FY 2019: 14.5×FY 2020: 22.7×FY 2021: 14.5×FY 2022: 13.7×FY 2023: 7.5×FY 2024: 7.3×FY 2025: 7.2×
FY 2016 5y median 7.5× FY 2025
FCF Yield 8.0%
FY 2016: -4.3%FY 2017: 4.8%FY 2018: -2.6%FY 2019: -3.5%FY 2020: 0.9%FY 2021: 5.3%FY 2022: 3.0%FY 2023: 7.7%FY 2024: 7.7%FY 2025: 8.0%
FY 2016 5y median 7.7% FY 2025

Profitability

Gross Margin 83.6%
FY 2016: 77.4%FY 2017: 90.2%FY 2018: 93.3%FY 2019: 76.8%FY 2020: 83.8%FY 2021: 81.6%FY 2022: 78.9%FY 2023: 76.8%FY 2024: 84.3%FY 2025: 83.6%
FY 2016 5y median 81.6% FY 2025
Operating Margin 57.5%
FY 2016: -56.7%FY 2017: 25.6%FY 2018: -45.7%FY 2019: -34.5%FY 2020: 53.9%FY 2021: 62.2%FY 2022: 40.5%FY 2023: 40.7%FY 2024: 54.3%FY 2025: 57.5%
FY 2016 5y median 54.3% FY 2025
Net Margin 22.7%
FY 2016: -70.2%FY 2017: 19.9%FY 2018: -52.9%FY 2019: -36.9%FY 2020: 48.2%FY 2021: 90.8%FY 2022: 30.6%FY 2023: 34.0%FY 2024: 43.7%FY 2025: 22.7%
FY 2016 5y median 34.0% FY 2025
ROE 649.2%
FY 2016: 317.2%FY 2017: 30.2%FY 2018: -32.3%FY 2019: -78.7%FY 2020: 85.5%FY 2021: 204.5%FY 2022: 119.0%FY 2023: 336.0%FY 2024: 122.1%FY 2025: 649.2%
FY 2016 5y median 204.5% FY 2025
ROIC 23.2%
FY 2016: -37.1%FY 2017: 17.4%FY 2018: -18.1%FY 2019: -13.5%FY 2020: 25.9%FY 2021: 25.6%FY 2022: 12.6%FY 2023: 16.8%FY 2024: 22.8%FY 2025: 23.2%
FY 2016 5y median 22.8% FY 2025
ROA 12.5%
FY 2016: -39.4%FY 2017: 12.1%FY 2018: -18.2%FY 2019: -12.8%FY 2020: 22.3%FY 2021: 36.5%FY 2022: 11.0%FY 2023: 16.2%FY 2024: 21.5%FY 2025: 12.5%
FY 2016 5y median 16.2% FY 2025

Growth (YoY)

Revenue 37.6%
FY 2016: 8.6%FY 2017: 115.8%FY 2018: -52.0%FY 2019: 29.1%FY 2020: 36.5%FY 2021: 65.7%FY 2022: 48.9%FY 2023: 25.6%FY 2024: 22.4%FY 2025: 37.6%
FY 2016 FY 2025
Operating Income 45.5%
FY 2016: -203.1%FY 2017: 197.3%FY 2018: -185.6%FY 2019: 2.5%FY 2020: 313.4%FY 2021: 91.3%FY 2022: -3.0%FY 2023: 26.2%FY 2024: 63.4%FY 2025: 45.5%
FY 2016 FY 2025
EPS (diluted) -25.4%
FY 2016: -224.0%FY 2017: 155.6%FY 2018: -224.4%FY 2019: 10.7%FY 2020: 282.0%FY 2021: 201.1%FY 2022: -47.4%FY 2023: 45.8%FY 2024: 63.3%FY 2025: -25.4%
FY 2016 FY 2025
Free Cash Flow 37.6%
FY 2016: -35.7%FY 2017: 348.0%FY 2018: -140.8%FY 2019: -65.2%FY 2020: 159.2%FY 2021: 462.8%FY 2022: -21.0%FY 2023: 58.6%FY 2024: 25.5%FY 2025: 37.6%
FY 2016 FY 2025

Financial Health

Current Ratio 4.7×
FY 2016: 4.7×FY 2017: 3.9×FY 2018: 2.9×FY 2019: 6.3×FY 2020: 1.3×FY 2021: 7.9×FY 2022: 5.7×FY 2023: 6.6×FY 2024: 7.8×FY 2025: 4.7×
FY 2016 5y median 6.6× FY 2025
Quick Ratio 3.7×
FY 2016: 4.4×FY 2017: 3.8×FY 2018: 2.7×FY 2019: 6.0×FY 2020: 1.2×FY 2021: 7.4×FY 2022: 4.9×FY 2023: 5.5×FY 2024: 6.8×FY 2025: 3.7×
FY 2016 5y median 5.5× FY 2025
Debt / Equity 43.9×
FY 2016: -6.7×FY 2017: 1.0×FY 2018: 0.5×FY 2019: 4.4×FY 2020: 2.6×FY 2021: 4.5×FY 2022: 8.9×FY 2023: 17.9×FY 2024: 4.1×FY 2025: 43.9×
FY 2016 5y median 8.9× FY 2025
Net Debt / EBITDA 3.5×
FY 2016: -1.9×FY 2017: 0.4×FY 2018: -1.0×FY 2019: -5.0×FY 2020: 1.6×FY 2021: 2.9×FY 2022: 4.0×FY 2023: 3.1×FY 2024: 2.1×FY 2025: 3.5×
FY 2016 5y median 3.1× FY 2025
Interest Coverage 44.3×
FY 2016: -4.2×FY 2017: 3.7×FY 2018: -3.8×FY 2019: -5.8×FY 2020: 7.1×FY 2021: 36.7×FY 2022: 15.8×FY 2023: 18.0×FY 2024: 30.5×FY 2025: 44.3×
FY 2016 5y median 30.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31